DuChemBio Co (XKRX:176750) Debt-to-Equity : 1.00 (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is DuChemBio Co Debt-to-Equity?

DuChemBio Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩14,726 Mil. DuChemBio Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩7,030 Mil. DuChemBio Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₩21,794 Mil. DuChemBio Co's debt to equity for the quarter that ended in Dec. 2023 was 1.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for DuChemBio Co's Debt-to-Equity or its related term are showing as below:

XKRX:176750' s Debt-to-Equity Range Over the Past 10 Years
Min: -50.39 Med: -2.15 Max: 1.54
Current: 1

During the past 8 years, the highest Debt-to-Equity Ratio of DuChemBio Co was 1.54. The lowest was -50.39. And the median was -2.15.

XKRX:176750's Debt-to-Equity is ranked worse than
85.46% of 853 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs XKRX:176750: 1.00

DuChemBio Co Debt-to-Equity Historical Data

The historical data trend for DuChemBio Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DuChemBio Co Debt-to-Equity Chart

DuChemBio Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

-50.39

-3.53

1.54

1.00

DuChemBio Co Semi-Annual Data
	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Debt-to-Equity	Get a 7-Day Free Trial			-50.39	-3.53	1.54	1.54	1.00

Competitive Comparison of DuChemBio Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, DuChemBio Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DuChemBio Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DuChemBio Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where DuChemBio Co's Debt-to-Equity falls into.

DuChemBio Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

DuChemBio Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(14725.659	+	7029.692)	/	21794.391
	=	1.00

DuChemBio Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(14725.659	+	7029.692)	/	21794.391
	=	1.00

DuChemBio Co (XKRX:176750) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

DuChemBio Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of DuChemBio Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

DuChemBio Co (XKRX:176750) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DuChemBio Co Ltd (XKRX:176750) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

Daegu 47, Jinyang Building, 4th floor, Chungjeong-ro 2, Gyeonggi, Seoul, KOR, 190-3

Website

http://www.duchembio.com

DuChemBio Co Ltd is engaged in manufacturing and sale of radiopharmaceuticals and radioactive medicines. It also imports and sells medical equipment related to nuclear medicines.

DuChemBio Co (XKRX:176750) Headlines

No Headlines